CoChat

Reference measurement procedure for CSF amyloid beta (Aβ)1–42 and the CSF Aβ1–42/Aβ1–40 ratio – a cross‐validation study against amyloid PET

Pannee, Josef, Portelius, Erik, Minthon, Lennart, Gobom, Johan, Andreasson, Ulf, Zetterberg, Henrik, Hansson, Oskar, Blennow, Kaj · 2016 · Journal of Neurochemistry
Cited by 85

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

A clinical diagnosis of Alzheimer's disease is currently made on the basis of results from cognitive tests in combination with medical history and general clinical evaluation, but the peptide amyloid‐beta (Aβ) in cerebrospinal fluid (CSF) is increasingly used as a biomarker for amyloid pathology in clinical trials and in recently proposed revised clinical criteria for Alzheimer's disease. Recent analytical developments have resulted in mass spectrometry (MS) reference measurement procedures for absolute quantification of Aβ 1–42 in CSF. The CSF Aβ 1–42/Aβ 1–40 ratio has been suggested to improve the detection of cerebral amyloid deposition, by compensating for inter‐individual variations in total Aβ production. Our aim was to cross‐validate the reference measurement procedure as well as the Aβ 1–42/Aβ 1–40 and Aβ 1–42/Aβ 1–38 ratios in CSF, measured by high‐resolution MS, with the cortical level of Aβ fibrils as measured by amyloid (18 F‐flutemetamol) positron emission tomography (PET). We included 100 non‐demented patients with cognitive symptoms from the Swedish Bio FINDER study, all of whom had undergone both lumbar puncture and 18 F‐flutemetamol PET. Comparing CSF Aβ 1–42 concentrations with 18 F‐flutemetamol PET showed high concordance with an area under the receiver operating characteristic curve of 0.85 and a sensitivity and specificity of 82% and 81%, respectively. The ratio of Aβ 1–42/Aβ 1–40 or Aβ 1–42/Aβ 1–38 significantly improved concordance with an area under the receiver operating characteristic curve of 0.95 and a sensitivity and specificity of 96% and 91%, respectively. These results show that the CSF Aβ 1–42/Aβ 1–40 and Aβ 1–42/Aβ 1–38 ratios using the described MS method are strongly associated with cortical Aβ fibrils measured by 18 F‐flutemetamol PET. image

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jnc.13838

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 85

Metadata

Authors
Pannee, J., Portelius, E., Minthon, L., Gobom, J., Andreasson, U., Zetterberg, H., Hansson, O., & Blennow, K.
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2016-09-30
Volume
139
Issue
4
Pages
651-658
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W2526756851
Cited by
85
References
20
FWCI
8.21
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Reference measurement procedure for CSF amyloid beta (Aβ)1–42 and the CSF Aβ1–42/Aβ1–40 ratio – a cross‐validation study against amyloid PET. https://app.cochat.ai/papers/10.1111/jnc.13838
The paper
Pannee, J., Portelius, E., Minthon, L., Gobom, J., Andreasson, U., Zetterberg, H., Hansson, O., & Blennow, K. (2016). Reference measurement procedure for CSF amyloid beta (Aβ)1–42 and the CSF Aβ1–42/Aβ1–40 ratio – a cross‐validation study against amyloid PET. Journal of Neurochemistry. https://doi.org/10.1111/jnc.13838

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.